M&A/IPOs

India’s Zenex Animal Health buys Netherlands-based VievePharm

Zenex Animal Health, an animal health company based in western India and backed by private equity firm Multiples PE, has bought Netherlands-based VievePharm, which specialises in natural animal health and nutrition products.

March 6, 2026

Australian CRO SSR invests in Singapore’s Expecto Health Science

Southern Star Research (SSR), an Australian clinical research organisation (CRO) backed by private equity firm Quadrant, has invested growth capital in Singapore-headquartered CRO Expecto Health Science. With this investment, the two CROs will form a strategic partnership to facilitate transition for sponsors from early-phase studies in Australia and New Zealand into late-phase clinical development across key Asian markets.

February 26, 2026

Sovereign Capital Partners buys Apollo Home Healthcare

Sovereign Capital Partners, a UK private equity firm, has acquired healthcare-at-home service provider Apollo Home Healthcare. Apollo is a primary provider of nurse-led complex care at home for individuals eligible for NHS Continuing Healthcare (CHC) funding. It provides personalised high-acuity care, with a focus on children and adults with complex clinical needs, acting as a commissioned provider for the NHS to deliver care packages that are fully funded by the health service.

February 26, 2026

Hims & Hers acquires Australian digital health platform Eucalyptus

Hims & Hers, the US-based telehealth platform, has acquired Australian digital health platform Eucalyptus in a US$1.15 billion deal, its largest acquisition to date.

February 26, 2026

Ramsay proposes to spin off French hospital subsidiary Santé via in-specie share distribution

Ramsay Health Care, Australia’s largest private hospital group, has announced plans to separate its European arm, Ramsay Santé, by distributing its shares directly to its existing shareholders through an in-specie distribution.

February 24, 2026

Synlab selling Slovakian operations to Unilabs

Pan-European diagnostic labs group Synlab has exited another market. It has sold its Slovakian operations to Unilabs, another pan-European diagnostics group, as part of its strategy to “densify its network”.

February 19, 2026

Italian insurer Reale Mutua to buy Lifenet and create integrated payor-provider

Italian insurer Reale Mutua is set to buy an 80% stake in Lifenet Healthcare, a hospital and outpatient services group in the north of the country, from Exor, the investment firm owned by the Agnelli family, and the company’s founder, in a deal reportedly worth around €600 million.

February 19, 2026

Hayfin leads Alantra’s €155m CV for genomics company Health in Code

Alantra, a Spanish private equity firm focused on mid-market transactions, has closed a €155 million healthcare continuation fund to support the next phase of growth at Health in Code (HiC), a clinical genomics company it has backed since 2020. The fund was oversubscribed and led by Hayfin Capital Management, a London-headquartered lending firm, alongside other […]

February 19, 2026

Genesis Capital buys Czech outpatient rehabilitation service provider Fyzioterapie s úsměvem

Genesis Capital, a private equity firm focused on small and medium-sized companies in Central Europe, has acquired a majority stake in a private outpatient rehabilitation service provider in the Czech Republic, Fyzioterapie s úsměvem.

February 19, 2026

GRO Capital exits audiology software provider Auditdata

Northern European private equity firm GRO Capital has exited Auditdata, an audiology software provider for hearing care, after ten years.

February 19, 2026

Older posts

Newer posts

M&A/IPOs

March 6, 2026

February 26, 2026

February 26, 2026

February 26, 2026

February 24, 2026

February 19, 2026

February 19, 2026

February 19, 2026

February 19, 2026

February 19, 2026

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.